Dan Burge

Chief Medical Officer at Seal Rock Therapeutics

Dan has participated in drug development since 1994 as an executive in biotech/pharmaceutical companies, as a consultant and as a principal investigator. Most recently, Dan was the SVP of clinical development at Dermira where he led the development of monoclonal antibodies for psoriasis and atopic dermatitis. Previous executive roles include Gilead (vice president, clinical development), Trubion Pharmaceuticals (senior vice president and chief medical officer), Amgen (vice president, clinical development), and Immunex (vice president, clinical development).


Org chart

Sign up to view 4 direct reports

Get started



Offices

This person is not in any offices